ALGERT GLOBAL LLC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1275218 SAN FRANCISCO, CA

Position in CRNX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$3,552,168

+$2,670,503 QoQ

Shares Held

97,802

+272.1% QoQ

Ownership

0.093%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ALGERT GLOBAL LLC holds $437,724,004 across 106 Biotechnology names. CRNX ranks #41 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	827,454	$22,920,475
2	AXSM	Axsome Therapeutics, Inc.	135,460	$22,895,449
3	SNDX	Syndax Pharmaceuticals Inc	928,568	$21,691,348
4	PCVX	Vaxcyte, Inc.	363,984	$21,151,110
5	BBIO	BridgeBio Pharma, Inc.	283,921	$21,083,973
6	XENE	Xenon Pharmaceuticals Inc.	264,200	$15,363,230
7	MRNA	Moderna, Inc.	237,418	$12,060,834
8	VRDN	Viridian Therapeutics, Inc.DE	563,999	$11,031,820

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,552,168	97,802	+272.1%	Shares	Sole	2026-05-14
2025-03-31	$881,665	26,287	-8.7%	Shares	Sole	2025-05-13
2024-12-31	$1,471,368	28,777	-32.7%	Shares	Sole	2025-02-14
2024-09-30	$2,185,904	42,777	+2.6%	Shares	Sole	2024-11-12
2024-06-30	$1,868,056	41,707	+19.0%	Shares	Sole	2024-08-15
2024-03-31	$1,640,222	35,040	+98.2%	Shares	Sole	2024-05-15
2023-12-31	$629,054	17,680	-5.5%	Shares	Sole	2024-02-14
2023-03-31	$300,482	18,710	+7.5%	Shares	Sole	2023-05-12
2022-12-31	$318,529	17,406	0.0%	Shares	Sole	2023-02-14
2022-09-30	$341,853	17,406	-13.3%	Shares	Sole	2022-11-15
2022-06-30	$374,473	20,079	-19.6%	Shares	Sole	2022-08-15
2022-03-31	$547,850	24,959	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.